Humana Inc. (NYSE:HUM) Shares Sold by First Commonwealth Financial Corp PA

First Commonwealth Financial Corp PA decreased its holdings in shares of Humana Inc. (NYSE:HUM) by 5.0% in the 4th quarter, HoldingsChannel.com reports. The firm owned 1,861 shares of the insurance provider’s stock after selling 98 shares during the period. First Commonwealth Financial Corp PA’s holdings in Humana were worth $472,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Transcend Capital Advisors LLC boosted its holdings in Humana by 399.7% during the fourth quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider’s stock worth $924,000 after buying an additional 2,914 shares in the last quarter. FNY Investment Advisers LLC boosted its stake in shares of Humana by 6,647.5% during the 4th quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider’s stock worth $6,916,000 after acquiring an additional 26,856 shares in the last quarter. Retirement Systems of Alabama boosted its stake in shares of Humana by 735.9% during the 4th quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock worth $55,563,000 after acquiring an additional 192,801 shares in the last quarter. Charles Schwab Investment Management Inc. grew its holdings in shares of Humana by 7.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider’s stock worth $244,811,000 after acquiring an additional 65,735 shares during the last quarter. Finally, Secure Asset Management LLC acquired a new stake in shares of Humana during the fourth quarter worth $244,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Trading Down 7.4 %

Shares of HUM stock opened at $264.41 on Friday. The business’s 50 day moving average is $265.75 and its two-hundred day moving average is $269.97. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46. The company has a market cap of $31.91 billion, a PE ratio of 26.57, a price-to-earnings-growth ratio of 2.05 and a beta of 0.62.

Humana (NYSE:HUM) last announced its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Equities analysts predict that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.34%. Humana’s payout ratio is 35.58%.

Analyst Upgrades and Downgrades

HUM has been the topic of a number of analyst reports. Piper Sandler lifted their price target on Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 15th. Morgan Stanley cut their price target on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a report on Wednesday, February 12th. Barclays raised their price objective on shares of Humana from $270.00 to $322.00 and gave the stock an “equal weight” rating in a research note on Friday, April 11th. Robert W. Baird boosted their target price on shares of Humana from $270.00 to $300.00 and gave the company a “neutral” rating in a research note on Tuesday. Finally, Truist Financial lifted their price target on Humana from $290.00 to $325.00 and gave the company a “hold” rating in a report on Friday, April 11th. Seventeen analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, Humana presently has a consensus rating of “Hold” and a consensus price target of $284.90.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.